Fingerprint
Dive into the research topics of 'Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: A randomized phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: A randomized phase II trial
D. Rayson, T. M. Suter, C. Jackisch, S. Van der Vegt, B. Bermejo, J. Van den Bosch, G. L. Vivanco, A. M. Van Gent, H. Wildiers, A. Torres, L. Provencher, M. Temizkan, J. Chirgwin, J. L. Canon, G. Ferrandina, S. Srinivasan, L. Zhang, D. J. Richel
Research output: Contribution to journal › Article › peer-review
36
Citations
(Scopus)